ARTICLE | Finance

Royalty replay

What OrbiMed plans to do with new $924M royalty, debt fund

February 9, 2015 8:00 AM UTC

With its first royalty fund fully deployed and returning cash, OrbiMed Advisors closed a second royalty fund that is 50% larger and recruited new LPs at research and healthcare institutions that could also help source deals.

The firm plans to make its first investment this quarter from OrbiMed Royalty Opportunities II, which will make about 15 investments of $20-$150 million across the healthcare sector in companies with commercialized products. Investments will include acquisitions of royalty streams and debt deals. ...